Bart Burgess

September 22, 2020, Cambridge, MA—Portal Instruments is pleased to announce the appointment of Mr. Bart Burgess as Associate Vice President Product Management and Strategy, effective August 31, 2020. Mr. Burgess will help define and execute Portal’s product strategy and  lead the development of  strategic business partnerships. He will report directly to the company CEO, Dr. Patrick Anquetil.


“Bart brings to Portal a strong and unique combination of backgrounds in pharmaceuticals, drug delivery and drug-device combination products,” said Dr. Anquetil. “Bart will lead our business development efforts and focus on advancing our drug delivery platform, including our digital capabilities.”


Burgess joins Portal from Regeneron Pharmaceuticals as Director of Combination Product Development and Industrialization, where he led the evaluation and development of new drug delivery technologies to support Regeneron’s portfolio of biopharmaceuticals. Prior to Regeneron, Burgess led business development for West Pharmaceutical Service’s self-injection device platforms, involving numerous drug delivery devices and partnership agreements. 


“With two major partnerships and a clear regulatory pathway, this is an exciting time to be joining Portal Instruments,” said Mr. Burgess.  “I am thrilled to join such a smart and dedicated team and look forward to driving the business forward.”


About Portal Instruments

Portal Instruments is developing and commercializing a highly innovative needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for chronic diseases. Portal’s needle-free delivery technology is derived from research at MIT and enables the administration of high viscosity biologic drugs with less discomfort and without the anxiety of handling needles. Real time tracking and reporting sets a new standard for monitoring adherence and potentially improving patient outcomes. Portal Instruments is ISO 13485:2012 certified. For more information, please visit: or follow @portalcambridge on Twitter.



Dr. Patrick Anquetil

Chief Executive Officer

Portal’s platform is in development and not available for sale or use.